Medivolve Signs Agreement to Acquire Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States
May 06, 2021 07:00 ET
|
Medivolve Inc.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and...
Medivolve and Marvel Diagnostics Successfully Complete First Stage Clinical Testing of BlowFISH, a Non-Invasive Exhaled Breath Diagnostic Technology For COVID-19, Developed by a UCLA Research Team Led by Dr. Pirouz Kavehpour
May 05, 2021 07:00 ET
|
Medivolve Inc.
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic...
Medivolve Announces Appointment of David Preiner as New Chief Executive Officer
April 30, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies,...
Medivolve Announces an Investor Webinar Today at 1 pm ET
April 15, 2021 10:40 ET
|
Medivolve Inc.
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, on Thursday, April 15th at 1...
Collection Sites Makes Affordable FDA EUA Approved COVID-19 At-Home Testing Available Nationwide
April 08, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC), a healthcare company that focuses on commercializing technologies to help combat COVID-19,...
Medivolve Subsidiary Collection Sites Provides March Sales Update With Total Sales of 20,574 Tests at an Average Price of $99 per Test
April 06, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to provide a sales update for its wholly owned subsidiary, Collection Sites, LLC....
Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring Through Its Mobile Testing Centres
April 01, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer...
Medivolve Signs Agreement With California Lab, Transplant Genomics, to Offer Free COVID-19 PCR Tests Through HRSA Program
March 30, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that its wholly-owned subsidiary Collection Sites, LLC has signed an...
CORRECTING AND REPLACING - Collection Sites Launches Business to Business Sales Initiatives; Provides Update With February Sales of 30,717 Tests at an Average Price of $98 per Test
March 18, 2021 10:38 ET
|
Medivolve Inc.
TORONTO, March 18, 2021 (GLOBE NEWSWIRE) -- We were informed by the client Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC), in the fifth paragraph, the month January should be February....
Collection Sites Launches Business to Business Sales Initiatives; Provides Update With February Sales of 30,717 Tests at an Average Price of $98 per Test
March 18, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, March 18, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to provide investors with a sales update and announces the launch of a new business...